Table 1 Patient characteristics (n = 16
From: A standardized approach to treat complex aortic valve endocarditis: a case series
| Characteristic | Value |
| Age: median [range] (years) | 63 [31–77] |
| Gender: male; female, n (%) | 14 (87.5); 2 (12.5) |
| Reoperation / PVE (%) | 75 |
| Follow-up survivors: median [range] (years) | 4.6 [2.3–11.7] |
| NYHA score: median [range] | III [II-IV] |
| Logarithmic EuroSCORE I: median [range] | 40.7 [12.8–68.3] |
| Microbiology | |
| PVE | |
| • Staphylococcus spp.: 5 CoNS, 1 S. aureus | n = 6 (50%) |
| • Streptococcus spp.: 1 viridans group, 1 S. bovis, 1 S. agalactiae | n = 3 (25%) |
| • Enterococcus spp.: 2 E. faecalis | n = 2 (17%) |
| • no micro-organism identified | n = 1 (8%) |
| NVE | |
| • Staphylococcus spp.: S. aureus | n = 1 (25%) |
| • Streptococcus spp.: 2 viridans group | n = 2 (50%) |
| • Enterococcus spp.: E. faecalis | n = 1 (25%) |
| Outcome | Value |
| Cardiopulmonary bypass perfusion time: median [range] (minutes) | 358 [186–731] |
| Aortic cross-clamping time: median [range] (minutes) | 266 [107–389] |
| Intensive care unit stay: median [range] (days) | 1.5 [1–21] |
| Hospital stay: median [range] (days) | 55 [29–90] |
| In-hospital mortality: n (%) | 3 (18.8) |
| 30 day mortality: n (%) | 2 (12.5) |